Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2003
08/28/2003WO2002036820A3 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
08/28/2003WO2002036610A3 Haplotypes of the adora3 gene
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002034922A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
08/28/2003WO2002033126A3 Solid support assay systems and methods utilizing non-standard bases
08/28/2003WO2002031209A3 Genes related to development of refractory prostate cancer
08/28/2003WO2002029097A3 Methods relating to polymorphisms in the human gpr10 gene
08/28/2003WO2002027035A3 High-throughput gene cloning and phenotypic screening
08/28/2003WO2002027022A3 Methods for diagnosing and treating autosomal dominant optic atrophy
08/28/2003WO2002026818A3 Human nedd-1
08/28/2003WO2002018646A3 Gene discovery using microarrays
08/28/2003WO2002018638A3 Detection of cyp2d6 polymorphisms
08/28/2003WO2002012499A3 Haplotypes of the ntf3 gene
08/28/2003WO2002012498A3 Haplotypes of the isl1 gene
08/28/2003WO2002012470A3 A member of the lysyl oxidase gene family
08/28/2003WO2002012342A3 Haplotypes of the edg4 gene
08/28/2003WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
08/28/2003WO2002010763A3 Marker for antidepressant therapy and methods related thereto
08/28/2003WO2002010708A3 Hygiene monitoring
08/28/2003WO2002008399A3 Human kinases
08/28/2003WO2002006833A3 Improved non-luminescent substrate
08/28/2003WO2002006530A3 Methods and materials for assessing cancer aggressiveness
08/28/2003WO2002002823A3 Polynucleotide sequence assay
08/28/2003WO2002002805A3 Method for identification, separation and quantitative measurement of nucleic acid fragments
08/28/2003WO2002002780A3 Human serine-threonine kinase
08/28/2003WO2002000938A3 Methods and compositions for transcription-based nucleic acid amplification
08/28/2003WO2001081924A3 Reusable microarrays for quantifying low abundance proteins
08/28/2003US20030163846 Process for the genetic modification of a plant
08/28/2003US20030163840 Genetic engineering; modulation Dna metabolism
08/28/2003US20030163836 In situ detection of enzyme inhibitors
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162947 Rapid production of monoclonal antibodies
08/28/2003US20030162946 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162717 Suppression appetite; weight loss therapy
08/28/2003US20030162692 Follicle stimulating hormone stimulated genes and uses thereof
08/28/2003US20030162308 Orthogonal read assembly
08/28/2003US20030162306 Compositions and methods for genetic analyses
08/28/2003US20030162291 Clk-2, cex-7 and coq-4 genes, and uses thereof
08/28/2003US20030162285 Comprises pressing of reaction solution into reaction chamber; centrifuging-free; polymerase chain reactions
08/28/2003US20030162284 Comprises permeable micromatrices which encapsulate test compounds; high-throughput assay; drug screening
08/28/2003US20030162278 Use for development of human therapeutic proteins; amino acid sequences, allelic variants, isolated polypeptide, antibody and nucleic acids, transgenic non-human animal, culturing the host cell, genetic engineering
08/28/2003US20030162277 Calcium/calmodulin-dependent kinase
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162273 Modulation of sulfate permease for photosynthetic hydrogen production
08/28/2003US20030162266 When the primers hybridize to each other, the 3' terminal residue of one primer forms a mismatch with the altered or mutated nucleotide residue on the other primer, thus preventing primer extension
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/28/2003US20030162249 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm
08/28/2003US20030162243 A source of an enzyme, a sterilant-resistant chemical associated with the enzyme, and a substrate that reacts with the enzyme to form detectable enzyme-modified product to provide an indication of the failure of sterilization
08/28/2003US20030162242 Method of selectively determining glycated hemoglobin
08/28/2003US20030162241 Carnitine- containing biological fluid is at least partially oxidized with a carnitine dehydrogenase with the help of NAD+, and the concentration of the reaction product, NADH is determined
08/28/2003US20030162239 Total cysteine assay
08/28/2003US20030162237 Methods of monitoring enzyme activity
08/28/2003US20030162232 Bundling optical fibers
08/28/2003US20030162230 Measurement phosphorylation of protein
08/28/2003US20030162226 High speed screening; resolution of enantiomorphs by crystallization; bioavailability
08/28/2003US20030162222 Therapy, prophylaxis; hybrid models; incubation, calibration
08/28/2003US20030162221 Complexing, immunoprecipitation, analyzing
08/28/2003US20030162217 Method of identifying nucleic acids
08/28/2003US20030162216 Nucleic acid ligand diagnostic biochip
08/28/2003US20030162215 Using semiconductor nanoparticles; biopolymer labeled with avidin, biotin
08/28/2003US20030162214 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
08/28/2003US20030162213 Terminal-phosphate-labeled nucleotides and methods of use
08/28/2003US20030162212 Cancer sensitivity; human and veterinary medicine
08/28/2003US20030162211 Activation of transcription factor; immobilization on solid supports; monitoring signals
08/28/2003US20030162210 Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
08/28/2003US20030162209 PCR based high throughput polypeptide screening
08/28/2003US20030162207 Alzheimer's disease
08/28/2003US20030162204 Alcohol detection assembly
08/28/2003US20030162203 Medical diagnosis using chromosomes, nucleic acids
08/28/2003US20030162202 Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
08/28/2003US20030162201 Cloned DNA polymerases from Thermotoga and mutants thereof
08/28/2003US20030162199 Polymerase chain reactions; by-product inhibition
08/28/2003US20030162197 Method of detecting neoplastic or non-neoplastic cells
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030162195 Detecting cancer sensitivity using oligonucleotide detector
08/28/2003US20030162194 Diagnosis of diseases associated with apoptosis
08/28/2003US20030162193 Screening ratio between lipoxygenase and lipase enzymes
08/28/2003US20030162192 Polymorphisms associated with ion-channel disease
08/28/2003US20030162190 Immobilized nucleotide aptamer
08/28/2003US20030162185 Products comprising a support to which nucleic acids are fixed and their use as dna chips
08/28/2003US20030162184 Amplification; polymerase chain reactions
08/28/2003US20030162183 Array design system and method
08/28/2003US20030162182 Species-specific PCR assay for detection of Leishmania donovani in clinical samples of kala-azar and post kala-azar dermal leishmaniasis
08/28/2003US20030162181 DNA sequencing and gene identification
08/28/2003US20030162180 Calibrating test pattern; hybrid primers
08/28/2003US20030162178 Microspheres; colorimetric analysis; binding indicators
08/28/2003US20030162177 Human Tbx20 gene and uses
08/28/2003US20030162176 Complementary DNAs
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030162174 Detecting nucleic acid deletion sequences
08/28/2003US20030162171 Test kit for tuberculosis diagnosis by determining alanine dehydrogenase
08/28/2003US20030162170 Nucleic acids; antibody, antigen complex
08/28/2003US20030162169 Screening enzyme inhibitors
08/28/2003US20030162168 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
08/28/2003US20030162167 Hepatitis c virusl detection using Dna sequences; liver disorders; immunoassay
08/28/2003US20030162165 Chemical signal enhancement of dynamic intensity-based intracellular protein-and fluorophore-based redistribution assays for drug-screening
08/28/2003US20030162164 Comparative phenotype analysis of cells, including testing of biologically active compounds
1 ... 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 ... 3003